| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_be3928f66bb2545a8175c61c56146b9a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4418
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-286
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0056
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 |
| filingDate |
2014-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d751c4b1bcc6218829e241b1a45b70b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_84f871366bc80276e1fb6a8ac143a3e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c73a6609ae035afe0112e7184a479d9 |
| publicationDate |
2015-01-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2015008825-A1 |
| titleOfInvention |
Orally disintegrating tablet |
| abstract |
Disclosed is an orally disintegrating tablet which comprises (a) an active component, (b) a starch having an amylose content of 20 to 30mass% and a gelatinization degree of less than 10%, and (c) at least one inorganic excipient selected from the group consisting of magnesium silicate, calcium silicate and synthetic hydrotalcite. This orally disintegrating tablet is a single -layer tablet or a dry coated tablet which has both a core and an outer layer. The content of crystalline cellulose in the single-layer orally disintegrating tablet or in the outer layer of the dry-coated orally integrating tablet is 0 to 5mass%. |
| priorityDate |
2013-07-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |